AstraZeneca — Tempus oncology model statement of work (2025)

DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.

2025-04-171

BuyerThe purchasing organisation or named customer.

AstraZeneca AB1

VendorThe contracting supplier or AI provider, as named in the source.

Tempus AI1

SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.

Enterprise

Value $Dollar value exactly as the source states it: an award, order, licence fee or customer commitment. Empty when undisclosed. The summary says what the figure covers; figures can include non-AI services.

$35,000,0001

ScopeThe use case or service scope named in the source.

Oncology foundation model1

Contract typeThe vehicle as the source names it: IDIQ, task order, other transaction agreement, blanket purchase agreement, enterprise agreement.

Statement of Work1

1. sec.gov accessed 2026-11-11

Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.